Kuo CC - Search Results

1

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia.

Lin WH, Wu SY, Yeh TK, Chen CT, Song JS, Shiao HY, Kuo CC, Hsu T, Lu CT, Wang PC, Wu TS, Peng YH, Lin HY, Chen CP, Weng YL, Kung FC, Wu MH, Su YC, Huang KW, Chou LH, Hsueh CC, Yen KJ, Kuo PC, Huang CL, Chen LT, Shih C, Tsai HJ, Jiaang WT. Lin WH, et al. Among authors: kuo cc, kuo pc. J Med Chem. 2019 Dec 26;62(24):11135-11150. doi: 10.1021/acs.jmedchem.9b01229. Epub 2019 Dec 6. J Med Chem. 2019. PMID: 31721578

2

Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.

Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH. Chang JY, et al. Among authors: kuo yh, kuo cc. Mol Pharmacol. 2004 Jan;65(1):77-84. doi: 10.1124/mol.65.1.77. Mol Pharmacol. 2004. PMID: 14722239

3

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.

Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Juang SH, et al. Among authors: kuo cc. Biochem Pharmacol. 2004 Jul 15;68(2):293-303. doi: 10.1016/j.bcp.2004.03.036. Biochem Pharmacol. 2004. PMID: 15194001

4

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Kuo CC, et al. Cancer Res. 2004 Jul 1;64(13):4621-8. doi: 10.1158/0008-5472.CAN-03-3474. Cancer Res. 2004. PMID: 15231674

5

Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.

Liou JP, Mahindroo N, Chang CW, Guo FM, Lee SW, Tan UK, Yeh TK, Kuo CC, Chang YW, Lu PH, Tung YS, Lin KT, Chang JY, Hsieh HP. Liou JP, et al. Among authors: kuo cc. ChemMedChem. 2006 Oct;1(10):1106-18. doi: 10.1002/cmdc.200600125. ChemMedChem. 2006. PMID: 16952120

6

2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.

Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP. Chang JY, et al. Among authors: kuo cc. J Med Chem. 2006 Oct 19;49(21):6412-5. doi: 10.1021/jm060616k. J Med Chem. 2006. PMID: 17034147

7

7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.

Chang JY, Hsieh HP, Chang CY, Hsu KS, Chiang YF, Chen CM, Kuo CC, Liou JP. Chang JY, et al. Among authors: kuo cc. J Med Chem. 2006 Nov 16;49(23):6656-9. doi: 10.1021/jm061076u. J Med Chem. 2006. PMID: 17154496

8

4- and 5-aroylindoles as novel classes of potent antitubulin agents.

Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY. Liou JP, et al. Among authors: kuo cc. J Med Chem. 2007 Sep 6;50(18):4548-52. doi: 10.1021/jm070557q. Epub 2007 Aug 8. J Med Chem. 2007. PMID: 17685504

9

Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells.

Ma LC, Kuo CC, Liu JF, Chen LT, Chang JY. Ma LC, et al. Among authors: kuo cc. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20. Mol Pharmacol. 2008. PMID: 18492797

10

Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.

Reddy GR, Kuo CC, Tan UK, Coumar MS, Chang CY, Chiang YK, Lai MJ, Yeh JY, Wu SY, Chang JY, Liou JP, Hsieh HP. Reddy GR, et al. Among authors: kuo cc. J Med Chem. 2008 Dec 25;51(24):8163-7. doi: 10.1021/jm8008635. J Med Chem. 2008. PMID: 19053773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,517 results

Search Page